Download presentation
Presentation is loading. Please wait.
Published bySami Marja-Leena Manninen Modified over 6 years ago
1
Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohort Shelley Ji Eun Hwang, MBBS (Hons), Giuliana Carlos, MBBS, Deepal Wakade, MD, Karen Byth, PhD, Benjamin Y. Kong, MBBS, Shaun Chou, MBBS, Matteo S. Carlino, MBBS, FRACP, Richard Kefford, MBBS, PhD, FRACP, Pablo Fernandez-Penas, MD, PhD, FACD Journal of the American Academy of Dermatology Volume 74, Issue 3, Pages e1 (March 2016) DOI: /j.jaad Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions
2
Fig 1 Estimated cumulative incidence of developing the first lichenoid reactions (A), eczema (B), and vitiligo (C) by months since commencement of treatment. Tick marks represent censored observations. Journal of the American Academy of Dermatology , e1DOI: ( /j.jaad ) Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.